Paperpal Prime Logo

Infection and Drug Resistance : Impact Factor & More

eISSN: 1178-6973pISSN: 1178-6973
JournalOpen Access

Key Metrics

CiteScore
5.6
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
Scite Index
0.79 5-Year SI
SJR
Q2Pharmacology
SNIP
1.37
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Infection and Drug Resistance

Infection and Drug Resistance Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Infection and Drug Resistance ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Infection and Drug Resistance

Molecular Epidemiology and Multilevel Drug Resistance Mechanisms of Escherichia coli in the Context of One Health: A Comprehensive Narrative Review
  • 3 Aug 2026
  • Infection and Drug Resistance
Evaluation of Virulence Profiles and Molecular Typing of ESBL-Producing Uropathogenic Escherichia coli: Dominance of ST131 and Emergence of ST421 in Iran
  • 3 Aug 2026
  • Infection and Drug Resistance
Repeated Spontaneous Transurethral Passage of Urinary Fungal Masses Associated with Candida tropicalis Candiduria in a Diabetic Patient with Multiple Urinary Calculi: A Case Report
  • 3 Aug 2026
  • Infection and Drug Resistance
Analysis of Clinical Characteristics and Risk Factors of Pediatric Macrolide-Resistant Mycoplasma pneumoniae Pneumonia from 2023 to 2025: A Single-Center Retrospective Study
  • 31 Jul 2026
  • Infection and Drug Resistance
Predicting Helicobacter pylori Antibiotic Resistance from Routine Hematoxylin and Eosin Histopathology Using a Vision-Language Model-Guided Foundation Model Framework
  • 31 Jul 2026
  • Infection and Drug Resistance
Epidemiological Characteristics and Antimicrobial Resistance of Prototheca Isolated in China During 2002\u20132024
  • 29 Jul 2026
  • Infection and Drug Resistance
Molecular Epidemiology and Multilevel Drug Resistance Mechanisms of Escherichia coli in the Context of One Health: A Comprehensive Narrative Review
  • 3 Aug 2026
  • Infection and Drug Resistance
Evaluation of Virulence Profiles and Molecular Typing of ESBL-Producing Uropathogenic Escherichia coli: Dominance of ST131 and Emergence of ST421 in Iran
  • 3 Aug 2026
  • Infection and Drug Resistance
Repeated Spontaneous Transurethral Passage of Urinary Fungal Masses Associated with Candida tropicalis Candiduria in a Diabetic Patient with Multiple Urinary Calculi: A Case Report
  • 3 Aug 2026
  • Infection and Drug Resistance
Analysis of Clinical Characteristics and Risk Factors of Pediatric Macrolide-Resistant Mycoplasma pneumoniae Pneumonia from 2023 to 2025: A Single-Center Retrospective Study
  • 31 Jul 2026
  • Infection and Drug Resistance
Predicting Helicobacter pylori Antibiotic Resistance from Routine Hematoxylin and Eosin Histopathology Using a Vision-Language Model-Guided Foundation Model Framework
  • 31 Jul 2026
  • Infection and Drug Resistance
Epidemiological Characteristics and Antimicrobial Resistance of Prototheca Isolated in China During 2002\u20132024
  • 29 Jul 2026
  • Infection and Drug Resistance

FAQs on Infection and Drug Resistance